Novavax COVID Vaccines Should Carry Heart Inflammation Warning, EU Says

Megan Redshaw

The European Medicines Agency today recommended adding a warning for two types of heart inflammation to Novavax’s COVID-19 vaccine, marketed under the brand names Nuvaxovid and Covovax, based on a small number of cases reported in those who received the vaccine.

… According to Reuters, the U.S. Food and Drug Administration (FDA) flagged a risk of heart inflammation from the Novavax vaccine in early June.

However, the agency on July 13 granted Novavax’s request for Emergency Use Authorization of the vaccine for adults 18 and over in the U.S.

… The FDA asked Novavax to “flag” myocarditis and pericarditis as an “important identified risk” in its materials accompanying the vaccine. However, Novavax has not yet agreed to do so.

… Novavax claimed that “natural background events” of myocarditis can be expected in any large database and the “totality of the clinical evidence” is “not enough to establish an overall causal relationship with the vaccine.”

Latest articles

Carolyn Beans How “forever chemicals” might impair the immune system Stain-resistant carpets...
Harold E. Buttram, Susan Kreider and Alan R. Yurko The writers of...
Carla Peeters A lingering disorder that can last for months or years...
el gato malo … the CDC just dramatically changed their claims about...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for healthcare choice!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!